1.800.979.8292

Caris Life Sciences™
Transforming Healthcare Into Human Care

Loading the player ...

Doctors need access to thorough and personalized diagnostic, prognostic and theranostic information so they can diagnose patients with greater accuracy and recommend therapies that are more likely to be effective — getting patients to the right treatments sooner. This idea is what drives us at Caris Life Sciences to provide services for doctors and their patients throughout the continuum of care.

Caris combines the rigor of an academic medical institution with the innovative spirit of a technology company. We serve thousands of patients each day through our sophisticated diagnostic, prognostic and theranostic services. We believe that better information can lead to more effective treatment selection and ultimately to better outcomes for patients with cancer and other complex diseases.

Our Services:

Caris Path™ Expert Pathology Services
Caris Life Sciences provides anatomic pathology services in the fields of dermatology, gastroenterology, hematology and urology. We also offer general surgery pathology services. Our specialists have a proven track record of accurately diagnosing difficult cases — from distinguishing between similar conditions, to accurately identifying the effects of medications and other factors.

read more

Caris Target Now™ Molecular Profiling
Caris Target Now examines the genetic and molecular makeup that is unique to each patient's tumor. By comparing the tumor's information with data from clinical studies from thousands of the world's leading cancer researchers, Caris can help the physician determine which treatments are likely to be most effective and which treatments are likely to be ineffective for each patient.

read more

Carisome™ Microvesicle Technology
Carisome is an innovative, proprietary and versatile testing technology that has the potential to detect disease in its earliest form, from a simple blood test. Currently being developed for a number of complex diseases including prostate, breast, lung and colorectal cancers, as well as cardiovascular disease, the technology has the potential to provide diagnostic, prognostic and theranostic information for patients throughout the continuum of care.

read more

Caris is a privately-held leader in biosciences, headquartered in the Dallas-Fort Worth Metroplex, with other U.S. laboratory operations in Phoenix, Arizona, and Boston, Massachusetts, and a globalization effort that has begun in Lausanne, Switzerland.